N-of-One is the leader in identifying patient-specific therapeutic options for precision medicine in oncology by leveraging its proprietary knowledgebase and its team of oncologists and Ph.D. scientists to integrate genomic data from multiple tests. Using N-of-One solutions can standardize and accelerate genomic clinical interpretation and molecular decision support while saving time and money. N-of-One's solutions have provided therapeutic options, including clinical trials, for tens of thousands of patient cases across hundreds of cancer types.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/21/16 | $7,000,000 | Series B |
Excel Venture Management Providence Ventures | undisclosed |
